肥満治療市場：医薬品、手術、デバイス別-2025～2030年の世界予測

肥満治療市場は、2023年に171億4,000万米ドルと評価され、2024年には188億8,000万米ドルに達すると予測され、CAGR 10.24％で成長し、2030年には339億3,000万米ドルに達すると予測されています。

肥満治療には、ライフスタイルの変化、薬物療法、外科的選択肢など、個人の健康的な体重の達成と維持を支援するためのさまざまな介入が含まれています。効果的な肥満治療の必要性は、糖尿病、心血管疾患、特定のがんなどの重大な健康リスクをもたらす肥満の世界の有病率の増加から生じています。アプリケーションはヘルスケアプロバイダー、ウェルネスプログラム、公衆衛生イニシアチブに及び、エンドユーザーは個人の患者から大規模な医療機関まで多岐にわたる。この分野の市場成長は、主に肥満関連の健康問題に対する意識の高まり、治療法の進歩、政府の支援政策によってもたらされます。主な影響要因としては、医療機器の技術革新、新薬の開発、モバイルヘルスアプリや遠隔医療サービスのようなデジタルヘルスソリューションの統合の増加などが挙げられます。最近の潜在的な治療機会は、遺伝的洞察を活用してオーダーメイドの治療計画を立案する個別化医療アプローチにあります。しかし、この業界は、治療費の高騰、規制上のハードル、肥満に関連する社会的烙印といった課題に直面しています。また、地域によってはヘルスケアへのアクセスが限られていることや、患者の治療アドヒアランスが一定していないことなどの限界もあります。技術革新のための最良の分野としては、非侵襲的治療法の開発、高度な行動療法技術、患者参加と転帰追跡を強化するための分野横断的パートナーシップなどが挙げられます。市場はダイナミックで多面的であり、急速な技術革新と激しい競合情勢が特徴です。企業は市場浸透を確実にするため、規制の複雑さを乗り越え、費用対効果の高いソリューションに注力しなければならないです。新たな機会を活用するために、企業は継続的な研究開発に投資し、デジタルトランスフォーメーション戦略を採用し、公衆衛生機関と連携してリーチと影響力を拡大する必要があります。これらの要因に対処することで、長期的な市場での成功を確保しながら、治療効果と患者のQOLの大幅な改善につながる可能性があります。

市場力学：急速に進化する肥満治療市場の主要市場インサイトを公開

肥満治療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の肥満人口の増加
  • 体重管理とフィットネスに関する意識の高まり
  • 肥満手術件数の増加
• 市場抑制要因
  • 製品回収と治療費の高騰
• 市場機会
  • 肥満手術機器の技術的進歩
  • 新しい低侵襲手術の調査
• 市場の課題
  • 治療薬に伴うリスク、合併症、副作用

ポーターの5つの力：肥満治療市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：肥満治療市場における外部からの影響の把握

外部マクロ環境要因は、肥満治療市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析肥満治療市場における競合情勢の把握

肥満治療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス肥満治療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、肥満治療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨肥満治療市場における成功への道筋を描く

肥満治療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界の肥満人口の蔓延率
    • 体重管理とフィットネスに関する意識の高まり
    • 肥満手術の増加
  • 抑制要因
    • 製品回収と高額な治療費
  • 機会
    • 肥満手術機器の技術的進歩
    • 新しい低侵襲肥満治療処置に関する調査
  • 課題
    • 治療に伴うリスク、合併症、副作用
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 肥満治療市場薬物別

• 食欲抑制剤
• 併用薬
• 吸収不良と満腹薬

第7章 肥満治療市場手術とデバイス

• 調節性胃バンディング
• 十二指腸スイッチによる胆膵バイパス術
• 内視鏡手術
• ルーワイ胃バイパス術
• スリーブ状胃切除術

第8章 南北アメリカの肥満治療市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の肥満治療市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの肥満治療市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• Apollo Endosurgery, Inc.
• Atkins Nutritionals, Inc.
• BTL Aesthetics
• C.H. Boehringer Sohn AG & Ko. KG
• Herbalife Ltd.
• Johnson & Johnson Services, Inc.
• Kellogg Company
• Medtronic PLC
• Novo Nordisk A/S
• NutriSystem, Inc.
• Olympus Corporation
• Pfizer, Inc.
• ReShape Lifesciences, Inc.
• Vivus, Inc.

LIST OF FIGURES

• FIGURE 1. OBESITY TREATMENT MARKET RESEARCH PROCESS
• FIGURE 2. OBESITY TREATMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL OBESITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL OBESITY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. OBESITY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. OBESITY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. OBESITY TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL OBESITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL OBESITY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. OBESITY TREATMENT MARKET DYNAMICS
• TABLE 7. GLOBAL OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL OBESITY TREATMENT MARKET SIZE, BY APPETITE SUPPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL OBESITY TREATMENT MARKET SIZE, BY COMBINATION DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL OBESITY TREATMENT MARKET SIZE, BY MALABSORPTION & SATIETY DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL OBESITY TREATMENT MARKET SIZE, BY BILIOPANCREATIC DIVERSION WITH DUODENAL SWITCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ENDOSCOPIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ROUX-EN-Y GASTRIC BYPASS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SLEEVE GASTRECTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 24. CANADA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 25. CANADA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 27. MEXICO OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 30. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 33. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 35. AUSTRALIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 36. CHINA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 37. CHINA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 38. INDIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 39. INDIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 41. INDONESIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 43. JAPAN OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 45. MALAYSIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 47. PHILIPPINES OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 49. SINGAPORE OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 51. SOUTH KOREA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 53. TAIWAN OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 55. THAILAND OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 57. VIETNAM OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 62. DENMARK OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 64. EGYPT OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 66. FINLAND OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 68. FRANCE OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 70. GERMANY OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 72. ISRAEL OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 73. ITALY OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 74. ITALY OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 76. NETHERLANDS OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 78. NIGERIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 80. NORWAY OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 81. POLAND OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 82. POLAND OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 83. QATAR OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 84. QATAR OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 86. RUSSIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 88. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 92. SPAIN OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 94. SWEDEN OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 96. SWITZERLAND OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 98. TURKEY OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 100. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 102. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
• TABLE 103. OBESITY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 104. OBESITY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

The Obesity Treatment Market was valued at USD 17.14 billion in 2023, expected to reach USD 18.88 billion in 2024, and is projected to grow at a CAGR of 10.24%, to USD 33.93 billion by 2030.

Obesity treatment encompasses a range of interventions designed to help individuals achieve and maintain a healthy weight, including lifestyle changes, pharmacotherapy, and surgical options. The necessity for effective obesity treatment arises from the growing global prevalence of obesity, which poses significant health risks such as diabetes, cardiovascular diseases, and certain cancers. The applications extend across healthcare providers, wellness programs, and public health initiatives, with end-users ranging from individual patients to large health organizations. Market growth in this sector is primarily driven by increasing awareness of obesity-related health issues, advancements in medical treatments, and supportive government policies. Key influencing factors include technological innovations in medical devices, the development of new pharmaceuticals, and the increasing integration of digital health solutions like mobile health apps and telehealth services. Recent potential opportunities lay in personalized medicine approaches, leveraging genetic insights to design tailored treatment plans. However, the industry faces challenges such as the high cost of treatments, regulatory hurdles, and societal stigma associated with obesity. Limitations include limited access to healthcare in some regions and inconsistent treatment adherence among patients. The best areas for innovation include the development of non-invasive treatment modalities, advanced behavioral therapy techniques, and cross-sector partnerships to enhance patient engagement and outcome tracking. The market is dynamic and multifaceted, characterized by rapid technological innovations and a highly competitive landscape. Companies must navigate regulatory complexities and focus on cost-effective solutions to ensure market penetration. To capitalize on emerging opportunities, businesses should invest in continuous research and development, embrace digital transformation strategies, and collaborate with public health agencies to expand their reach and impact. Addressing these factors can potentially lead to significant improvements in treatment efficacy and patient quality of life while securing long-term market success.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Obesity Treatment Market

The Obesity Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of obese population worldwide
  • Growing awareness regarding weight management and fitness
  • Growing number of bariatric surgeries
• Market Restraints
  • Product recall and high cost of treatment
• Market Opportunities
  • Technological advancements in obesity surgery devices
  • Research about new minimally invasive obesity treatment procedures
• Market Challenges
  • Associated risks, complications and side effects of treatment therapeutics

Porter's Five Forces: A Strategic Tool for Navigating the Obesity Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Obesity Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Obesity Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Obesity Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Obesity Treatment Market

A detailed market share analysis in the Obesity Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Obesity Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Obesity Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Obesity Treatment Market

A strategic analysis of the Obesity Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Obesity Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Apollo Endosurgery, Inc., Atkins Nutritionals, Inc., BTL Aesthetics, C.H. Boehringer Sohn AG & Ko. KG, Herbalife Ltd., Johnson & Johnson Services, Inc., Kellogg Company, Medtronic PLC, Novo Nordisk A/S, NutriSystem, Inc., Olympus Corporation, Pfizer, Inc., ReShape Lifesciences, Inc., and Vivus, Inc..

Market Segmentation & Coverage

This research report categorizes the Obesity Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Drugs, market is studied across Appetite Suppressants, Combination Drugs, and Malabsorption & Satiety Drugs.
• Based on Surgery & Devices, market is studied across Adjustable Gastric Banding, Biliopancreatic Diversion With Duodenal Switch, Endoscopic Procedures, Roux-en-Y Gastric Bypass, and Sleeve Gastrectomy.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of obese population worldwide
    • 5.1.1.2. Growing awareness regarding weight management and fitness
    • 5.1.1.3. Growing number of bariatric surgeries
  • 5.1.2. Restraints
    • 5.1.2.1. Product recall and high cost of treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in obesity surgery devices
    • 5.1.3.2. Research about new minimally invasive obesity treatment procedures
  • 5.1.4. Challenges
    • 5.1.4.1. Associated risks, complications and side effects of treatment therapeutics
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Obesity Treatment Market, by Drugs

• 6.1. Introduction
• 6.2. Appetite Suppressants
• 6.3. Combination Drugs
• 6.4. Malabsorption & Satiety Drugs

7. Obesity Treatment Market, by Surgery & Devices

• 7.1. Introduction
• 7.2. Adjustable Gastric Banding
• 7.3. Biliopancreatic Diversion With Duodenal Switch
• 7.4. Endoscopic Procedures
• 7.5. Roux-en-Y Gastric Bypass
• 7.6. Sleeve Gastrectomy

8. Americas Obesity Treatment Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Obesity Treatment Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Obesity Treatment Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Apollo Endosurgery, Inc.
• 3. Atkins Nutritionals, Inc.
• 4. BTL Aesthetics
• 5. C.H. Boehringer Sohn AG & Ko. KG
• 6. Herbalife Ltd.
• 7. Johnson & Johnson Services, Inc.
• 8. Kellogg Company
• 9. Medtronic PLC
• 10. Novo Nordisk A/S
• 11. NutriSystem, Inc.
• 12. Olympus Corporation
• 13. Pfizer, Inc.
• 14. ReShape Lifesciences, Inc.
• 15. Vivus, Inc.